Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders
Hiroki Ishiguro, Yasue Horiuchi, Koichi Tabata, et al.
Molecules (2018) Vol. 23, Iss. 8, pp. 1836-1836
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access | Times Cited: 3
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 46
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5526-5526
Open Access | Times Cited: 30
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 5
Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review
Marta Bryk, Katarzyna Starowicz
Pharmacological Reports (2021) Vol. 73, Iss. 3, pp. 681-699
Open Access | Times Cited: 31
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress
Rui S. Rodrigues, João B. Moreira, Joana M. Mateus, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Cannabinoids, interoception, and anxiety
Allyson K. Andrade, Briana Renda, Jennifer E. Murray
Pharmacology Biochemistry and Behavior (2019) Vol. 180, pp. 60-73
Closed Access | Times Cited: 30
The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression
Xiangjuan Kong, Qingshan Miao, Xiaozi Lu, et al.
Medicine (2019) Vol. 98, Iss. 46, pp. e17403-e17403
Open Access | Times Cited: 30
Constructive feedback on the link between depression and acute myocardial infarction: A response to recent findings
Adeeba Bilquees, Dauood Saleem, Mohd Aamir
International Journal of Cardiology (2025), pp. 133156-133156
Closed Access
A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes
Judit Lazáry, Nóra Eszlári, Gabriella Juhász, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 716-722
Closed Access | Times Cited: 27
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
José Antonio Estrada, Irazú Contreras
Current Neuropharmacology (2020) Vol. 18, Iss. 8, pp. 769-787
Open Access | Times Cited: 24
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Isadora Lopes Cortez, Naielly Rodrigues da Silva, Francisco Silveira Guimarães, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 24
Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety
Wenjiao Yang, Xudong Gong, Haiguo Sun, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116048-116048
Closed Access | Times Cited: 9
A systematic, integrative review of the effects of the endocannabinoid system on inflammation and neurogenesis in animal models of affective disorders
Juliette Giacobbe, Alessia Marrocu, Maria Grazia Di Benedetto, et al.
Brain Behavior and Immunity (2020) Vol. 93, pp. 353-367
Closed Access | Times Cited: 22
The antidepressant and anxiolytic effects of cannabinoids in chronic unpredictable stress: a preclinical systematic review and meta-analysis
Noa Reuveni, Cole A. Carlson, Sarah Schwartz, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Genetic-epigenetic-neuropeptide associations in mood and anxiety disorders: Toward personalized medicine
Maryam Gilani, Niloofar Abak, Mostafa Saberian
Pharmacology Biochemistry and Behavior (2024), pp. 173897-173897
Closed Access | Times Cited: 2
Contribution of CB2 receptors in schizophrenia-related symptoms in various animal models: Short review
Izabela Banaszkiewicz, Grażyna Biała, Marta Kruk-Słomka
Neuroscience & Biobehavioral Reviews (2020) Vol. 114, pp. 158-171
Closed Access | Times Cited: 17
Targeting Endocannabinoid System in Epilepsy: For Good or for Bad
Christopher Martínez-Aguirre, Reşat Çınar, Luísa Rocha
Neuroscience (2021) Vol. 482, pp. 172-185
Closed Access | Times Cited: 13
Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice
Ewa Poleszak, Sylwia Wośko, Karolina Sławińska, et al.
Behavioural Brain Research (2019) Vol. 378, pp. 112297-112297
Open Access | Times Cited: 14
Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice
Ewa Poleszak, Sylwia Wośko, Karolina Sławińska, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 188, pp. 172833-172833
Open Access | Times Cited: 14
Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
Hiroki Ishiguro
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 4
High-frequency repetitive transcranial magnetic stimulation regulates neural oscillations of the hippocampus and prefrontal cortex in mice by modulating endocannabinoid signalling
Zhengwu Peng, Cuihong Zhou, Shan‐Shan Xue, et al.
Journal of Affective Disorders (2023) Vol. 331, pp. 217-228
Closed Access | Times Cited: 4
Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
Natalia Mansur Haddad, Leonardo Peroni De Jesus, Maurício H. Serpa, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top